Studies on other DNA-PKi, and also inhibitors of ATM, ATR and PARP, did not find any therapeutically exploitable differences between photon and proton irradiation in HNSCC cell lines [94,95]. The gene discussed is PARP1; the disease is head and neck squamous cell carcinoma.